Advances in Headache

Integrated Neuroscience Session

Wednesday, April 29, 2:00–6:00 p.m.

The Advances in Headache Integrated Neuroscience Session will include platform and poster presentations highlighting emerging treatment modalities for acute and chronic primary headache disorders and new insights into the pathogenesis of primary and secondary headache disorders from advanced imaging techniques. Invited presentations will also include the Harold Wolff-John Graham headache/facial pain research award paper, recent developments in the understanding of the origin of migraine pain and migraine aura, and an overview of the migraine pipeline.

• IN4-1.001 Migraine Symptoms in Middle-Age Predict Brain Infarcts in Late-Life: A 25-Year Longitudinal Population-Based MRI Study, Ann I. Scher, PhD
• IN4-1.002 MRI with Intrathecal Gadolinium to Detect a Cerebrospinal Fluid Leak: Results of a Prospective Open Label Single Centre Observational Cohort, Ludo J. Vanopdenbosch, MD
• IN4-1.003 Interictal Sensitization in Migraine, Todd J. Schwedt, MD
• IN4-1.004 Clinical and Neuroimaging Evidence of Interictal Cerebellar Dysfunction in FHM 2, Daniela Grimaldi, MD
• IN4-1.005 Transcranial Magnetic Stimulation for the treatment of migraine aura, Philip R. Holland, PhD
• IN4-1.006 Clinical Profile of the Novel Oral CGRP Receptor Antagonist Telcagepant for the Acute Treatment of Migraine in Two Phase 3 Randomized Placebo-controlled Trials, Tony W. Ho, MD

• IN4-2.001 Single Nucleotide Polymorphisms of the Serotonin Transporter Gene in Migraine, Bettina Bayerer, PhD
• IN4-2.002 Aura Does Not Predict Right-to-Left Shunt in Patients with Chronic Migraine, Ashley G. Kim, BS
• IN4-2.003 Auditory Hallucinations in Adults with Migraine, Sara Tarshish, MD
• IN4-2.004 Gray Matter Decrease in Patients with Trigeminal Neuralgia, Mark Obermann, MD
• IN4-2.005 Occipital Nerve Stimulation (ONS) for Treatment of Intractable Chronic Migraine (ICM): 3-Month Results from the ONSTIM Feasibility Study, Joel Saper, MD
• IN4-2.006 Ictal brain 5-HT_1A receptor binding in migraineurs, Genevieve Demarquay, MD
• IN4-2.007 Cerebral Venous Sinuses Diameter Variation in Response to Lumbar Puncture in Idiopathic Intracranial Hypertension, Anat Horev, MD
• IN4-2.008 Refractory Chronic Cluster Headache treated by Deep Brain Stimulation: a French Multicentric Randomized Placebo-Controlled Double-Blind Trial, Michel Lanteri-Minet, MD
• IN4-2.009 Hemicrania Continua and Unilateral Chronic Migraine Indometacin Negative: A Clinical Comparison Study, Elisabetta Cittadini, MD
• IN4-2.010 New Daily Persistent Headache in the Pediatric Population, Eric Kung, MD

• Harold Wolff-John Graham Award: An Award for Headache/Facial Pain Research Presentation

• 4:45–5:05 p.m. The Origin of Migraine Pain, Rami Burstein, PhD
• 5:05–5:25 p.m. Migraine Aura: Recent Developments and Mechanistic Understanding, Andrew Charles, MD
• 5:25–5:45 p.m. The Migraine Pipeline: An Update, Peter Goadsby, MD, PhD
• 5:45–6:00 p.m. Panel Discussion